^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
Target Selector™ EGFR Mutation Assay

Company:
Biocept
Type:
CE Marked
Related tests:

Details

Evidence
News
The Target Selector™ EGFR Assay detects EGFR mutation in DNA derived from blood plasma or FFPE tissue sections to give insight into cancer characteristics and provide Biomarker status of tumors such as non-small cell lung cancer. It helps in Detection of Del19, L858R, T790M as well as wild-type are quantitative
Cancer:
Non Small Cell Lung Cancer
Gene:
EGFR (Epidermal growth factor receptor)
Method:
Next-Generation Sequencing (NGS)
Approvals
Date
Cancer
Gene
Drug
By
04/28/20
CE